Clinical Education InitiativeMenu
SEARCH
Home > Courses > ACTHIV 2016 Conference - Important Drug-Drug Interactions with Antiretroviral and Hepatitis C Drugs

ACTHIV 2016 Conference - Important Drug-Drug Interactions with Antiretroviral and Hepatitis C Drugs

ACTHIV 2016 Conference - Important Drug-Drug Interactions with Antiretroviral and Hepatitis C Drugs
Play
Sorry, this learning module is not available for mobile devices.
ACTHIV
Original Release Date: 4/28/2016
Review Date: 9/15/2016

The enduring material is jointly provided by William Beaumont Hospital, American Academy of CME, Inc., and the American Conference for the Treatment of HIV (ACTHIV).

The 10th Annual American Conference for the Treatment of HIV (ACTHIV) was held April 28-30, 2016 in Dallas, TX. The Conference was supported by funding from the Clinical Education Initiative, New York State Department of Health, AIDS Institute; and from the HIV Medicine Association (HIVMA). The conference and this web archive were supported by educational grants from Bristol-Myers Squibb; Gilead Sciences; Janssen Therapeutics, Division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare.

ONLINE CE CREDIT:

This module is NO LONGER available for CE credit.

FACULTY:
Parya Saberi, PharmD, MAS, AAHIVP, is an Assistant Professor in the Department of Medicine at the University of California, San Francisco’s Center for AIDS Prevention Studies.

Estimated time to complete: 30 minutes

TARGET AUDIENCE
Physicians (both specialists and primary care/family medicine), nurse practitioners, and nurses who are frontline providers of care to persons at risk of or with HIV infection. Physician assistants, pharmacists, case managers and other healthcare professionals may also participate.

Learning Objectives
As a result of participating in this activity, participants should be better able to:

  • Recognize important drug-drug interactions between medications used for HIV and Hepatitis C treatment.
  • Examine options for avoiding or minimizing drug-drug interactions.
  • Identify resources to obtain up-to-date drug information on HIV and Hepatitis C drug-drug interactions.

Faculty Disclosure

Parya Saberi, PharmD, MAS, AAHIVP – no relevant financial relationships no disclose.

Privacy Policy
For more information about Beaumont's privacy policy, please access http://www.beaumont.edu/privacy-policy
For more information about Academy privacy policy, please access http://www.academycme.org/privacy.htm

For CME information or credit details, contact: cme@beaumont.edu

For CNE information or credit details, contact: CEservices@academycme.org

Bibliographic Sources:

Presenter
  • Parya Saberi, PharmD, MAS
    Assistant Professor
    University of California
Presenter Bio
Parya Saberi, PharmD, MAS
Parya Saberi, PharmD, MAS, AAHIVP, is an Assistant Professor in the Department of Medicine at the University of California, San Francisco’s Center for AIDS Prevention Studies. Her primary practice site is at San Francisco General Hospital where she is an HIV Clinical Pharmacist at Ward 86 (Positive Health Program).